Dixestivo

2020

1. Comment to “Biosimilars: The viewpoint of Italian patients with inflammatory bowel disease”

   Digestive and Liver Disease

2. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” (Pancreatology (2018) 18(8) (847–854), (S1424390318306938), (10.1016/j.pan.2018.09.016))

   Pancreatology

3. Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.00860)

   Frontiers in Pharmacology

4. Duration of organ failure impacts mortality in acute pancreatitis

   Gut

5. Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) (Journal of Hepatology (2020) 73(1) (17–25), (S0168827820301276), (10.1016/j.jhep.2020.02.028))

   Journal of Hepatology

6. Letter: now is the time to remove complexity from HCV guidelines to ensure that elimination remains a priority

   Alimentary Pharmacology and Therapeutics

7. Principles for Evaluation of Surveillance After Removal of Colorectal Polyps: Recommendations From the World Endoscopy Organization

   Gastroenterology

8. Should We Investigate Respiratory Diseases in Inflammatory Bowel Disease Patients?

   Archivos de Bronconeumologia

9. The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions

   Gastroenterologia y Hepatologia